Eli Lilly Switzerland Germany state Illinois state New York Washington state New Jersey hospital experts prevention medicines Health reports Manufacturing Eli Lilly Switzerland Germany state Illinois state New York Washington state New Jersey

Albuterol factory closure prompts concerns over ongoing asthma drug shortage

Reading now: 750
www.fox29.com

FILE - In this photo illustration lie two asthma inhalers in a handbag on Feb. 3, 2021 in Bonn, Germany. (Photo by Ute Grabowsky/Photothek via Getty Images) Concerns are growing over a common asthma drug – already in short supply – after one of the last major manufacturers in the U.S.

shut down its operations.Albuterol is used to prevent and treat difficulty breathing, wheezing, coughing, and chest tightness caused by lung diseases like asthma and chronic obstructive pulmonary disease (COPD), according to the National Library of Medicine.

It’s one of the most commonly prescribed medications in the U.S. and has been on the U.S. Food and Drug Administration’s shortage list since last fall.RELATED: Drugmaker Eli Lilly says it's cutting insulin prices by 70%In February, Illinois-based pharmaceutical company Akorn Operating Co.

abruptly closed all of its operations, including its out-of-state locations in New Jersey, New York and Switzerland, and laid off hundreds of workers amid plans to file for bankruptcy.The company developed, manufactured and marketed a wide array of branded and generic prescription drugs, including medication like Albuterol, as well as eye drops, injectables, and others, according to its website.

Read more on fox29.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA